Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alloway

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Transplantation|May 28, 2011
Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibitionR Carlin Walsh, Paul Brailey, Alin Girnita, et al.
Clinical Transplantation|May 20, 2019
Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor poolAnn Dao, Madison Cuffy, Tiffany E Kaiser, et al.
Clinical Transplants|September 30, 1999
Experience with portal-enteric pancreas transplant at the University of Tennessee-MemphisR J Stratta, A O Gaber, M H Shokouh-Amiri, et al.
Transplantation Direct|December 20, 2016
Successful Simultaneous Liver-Kidney Transplantation in the Presence of Multiple High-Titered Class I and II Antidonor HLA AntibodiesFlavio Paterno, Alin Girnita, Paul Brailey, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2023
Effects of invivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidatesAmy P Rossi, Simon Tremblay, Cyd M Castro-Rojas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 13, 2005
African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppressionRobyn E Boardman, Rita R Alloway, J Wesley Alexander, et al.
Transplantation Proceedings|April 26, 2005
African American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppressionR E Boardman, R R Alloway, J W Alexander, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 8, 2002
Evolving experience of hepatitis B virus prophylaxis in liver transplantationM R Honaker, M H Shokouh-Amiri, S R Vera, et al.
Transplantation|December 24, 2008
Bortezomib provides effective therapy for antibody- and cell-mediated acute rejectionMatthew J Everly, Jason J Everly, Brian Susskind, et al.
Transplantation Proceedings|April 26, 2005
A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experienceR R Alloway, M J Hanaway, J Trofe, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Transplantation|May 28, 2011
Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibitionR Carlin Walsh, Paul Brailey, Alin Girnita, et al.
Clinical Transplantation|May 20, 2019
Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor poolAnn Dao, Madison Cuffy, Tiffany E Kaiser, et al.
Clinical Transplants|September 30, 1999
Experience with portal-enteric pancreas transplant at the University of Tennessee-MemphisR J Stratta, A O Gaber, M H Shokouh-Amiri, et al.
Transplantation Direct|December 20, 2016
Successful Simultaneous Liver-Kidney Transplantation in the Presence of Multiple High-Titered Class I and II Antidonor HLA AntibodiesFlavio Paterno, Alin Girnita, Paul Brailey, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2023
Effects of invivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidatesAmy P Rossi, Simon Tremblay, Cyd M Castro-Rojas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 13, 2005
African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppressionRobyn E Boardman, Rita R Alloway, J Wesley Alexander, et al.
Transplantation Proceedings|April 26, 2005
African American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppressionR E Boardman, R R Alloway, J W Alexander, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 8, 2002
Evolving experience of hepatitis B virus prophylaxis in liver transplantationM R Honaker, M H Shokouh-Amiri, S R Vera, et al.
Transplantation|December 24, 2008
Bortezomib provides effective therapy for antibody- and cell-mediated acute rejectionMatthew J Everly, Jason J Everly, Brian Susskind, et al.
Transplantation Proceedings|April 26, 2005
A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experienceR R Alloway, M J Hanaway, J Trofe, et al.
Pageof 17